Pancreatic Cancer Research

ResearcherSt John of God Subiaco HospitalActive in the last 2 years

Andrew P. Barbour

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0991-7662; OpenAlex author ID A5053696810, A5072607971. Sources: OpenAlex.

Their work

Papers
16 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 16

  1. Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (… Co-author DOI 10.1016/s1470-2045(26)00532-2↗
  2. C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Last author DOI 10.1111/ajco.13993↗
  3. Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification. Co-author DOI 10.1158/2767-9764.crc-25-0229↗
  4. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Last author DOI 10.1053/j.gastro.2021.09.022↗
  5. Computed Tomography Radiomics Signatures: Sensitive biomarkers for clinical decision support in pancreatic cancer- a pilot study Co-author DOI 10.1101/2021.12.03.21267217↗
  6. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk an… Co-author DOI 10.1186/s12885-021-08666-y↗
  7. ROR1 and ROR2 expression in pancreatic cancer. Co-author DOI 10.1186/s12885-021-08952-9↗
  8. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/thno.43589↗
  9. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Co-author DOI 10.1038/s41467-019-10968-6↗
  10. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  11. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  12. Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. First author DOI 10.5694/mja16.00061↗
  13. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Last author DOI 10.1002/bjs.9892↗
  14. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  15. Surgical management in patients with pancreatic cancer: a Queensland perspective. Co-author DOI 10.1111/j.1445-2197.2012.06312.x↗
  16. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Goldstein · 5 shared papers, 2015–2025 · strength 0.56
  2. Jaswinder Singh Samra · 5 shared papers, 2015–2026 · strength 0.54
  3. Val Gebski · 4 shared papers, 2015–2025 · strength 0.49
  4. James G. Kench · 3 shared papers, 2015–2025 · strength 0.32
  5. Andrew Oar · 2 shared papers, 2021–2026 · strength 0.30
  6. Vanessa Bonazzi · 1 shared paper, 2025 · strength 0.21
  7. David Paul Goldstein · 1 shared paper, 2026 · strength 0.20
  8. Koroush Shahsavar Haghighi · 2 shared papers, 2016–2021 · strength 0.19
  9. Abbas Habibalahi · 1 shared paper, 2021 · strength 0.13
  10. Ewa Magdalena Goldys · 1 shared paper, 2021 · strength 0.13
  11. Nam Quoc Nguyen · 1 shared paper, 2021 · strength 0.10
  12. Lorraine A. Chantrill · 1 shared paper, 2021 · strength 0.10
  13. Ashleigh Parkin · 1 shared paper, 2020 · strength 0.08
  14. Marina Pajic · 1 shared paper, 2020 · strength 0.08
  15. John David Hooper · 1 shared paper, 2020 · strength 0.08
  16. Thomas Kryza · 1 shared paper, 2020 · strength 0.08
  17. Robert C. Gandy · 1 shared paper, 2016 · strength 0.06
  18. Mehrdad Nikfarjam · 1 shared paper, 2016 · strength 0.06
  19. Manju Dashini Chandrasegaram · 1 shared paper, 2015 · strength 0.05
  20. Neil Donald Merrett · 1 shared paper, 2015 · strength 0.05
  21. Anthony James Gill · 1 shared paper, 2015 · strength 0.05
  22. Neil Wylie · 1 shared paper, 2013 · strength 0.03
  23. Rachel Ε. Neale · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.